These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16810112)

  • 1. Range of normal neutrophil counts in healthy zimbabwean infants: implications for monitoring antiretroviral drug toxicity.
    Wells J; Shetty AK; Stranix L; Falkovitz-Halpern MS; Chipato T; Nyoni N; Mateta P; Maldonado Y
    J Acquir Immune Defic Syndr; 2006 Aug; 42(4):460-3. PubMed ID: 16810112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.
    Feiterna-Sperling C; Weizsaecker K; Bührer C; Casteleyn S; Loui A; Schmitz T; Wahn V; Obladen M
    J Acquir Immune Defic Syndr; 2007 May; 45(1):43-51. PubMed ID: 17356471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol.
    Mwinga K; Vermund SH; Chen YQ; Mwatha A; Read JS; Urassa W; Carpenetti N; Valentine M; Goldenberg RL
    BMC Pediatr; 2009 Aug; 9():49. PubMed ID: 19664210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutropenia in HIV-Infected Kenyan Women Receiving Triple Antiretroviral Prophylaxis to Prevent Mother-to-Child HIV Transmission Is Not Associated with Serious Clinical Sequelae.
    Iuliano AD; Weidle PJ; Brooks JT; Masaba R; Girde S; Ndivo R; Ogindo P; Omolo P; Zeh C; Thomas TK
    J Int Assoc Provid AIDS Care; 2015; 14(3):261-8. PubMed ID: 24080477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study.
    Pacheco SE; McIntosh K; Lu M; Mofenson LM; Diaz C; Foca M; Frederick M; Handelsman E; Hayani K; Shearer WT;
    J Infect Dis; 2006 Oct; 194(8):1089-97. PubMed ID: 16991083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants.
    Rovira N; Noguera-Julian A; Rives S; Berrueco R; Lahoz R; Fortuny C
    Eur J Pediatr; 2016 Jul; 175(7):1013-7. PubMed ID: 27165499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
    JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial.
    Flynn PM; Taha TE; Cababasay M; Fowler MG; Mofenson LM; Owor M; Fiscus S; Stranix-Chibanda L; Coutsoudis A; Gnanashanmugam D; Chakhtoura N; McCarthy K; Mukuzunga C; Makanani B; Moodley D; Nematadzira T; Kusakara B; Patil S; Vhembo T; Bobat R; Mmbaga BT; Masenya M; Nyati M; Theron G; Mulenga H; Butler K; Shapiro DE;
    J Acquir Immune Defic Syndr; 2018 Apr; 77(4):383-392. PubMed ID: 29239901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.
    Marazzi MC; Nielsen-Saines K; Buonomo E; Scarcella P; Germano P; Majid NA; Zimba I; Ceffa S; Palombi L
    Pediatr Infect Dis J; 2009 Jun; 28(6):483-7. PubMed ID: 19483516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.
    Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Maréchal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tylleskär T; Van de Perre P;
    Lancet; 2016 Feb; 387(10018):566-573. PubMed ID: 26603917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breastfeeding by HIV-1-infected women and outcome in their infants: a cohort study from Durban, South Africa.
    Bobat R; Moodley D; Coutsoudis A; Coovadia H
    AIDS; 1997 Nov; 11(13):1627-33. PubMed ID: 9365768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth.
    Taha TE; Kumwenda N; Kafulafula G; Kumwenda J; Chitale R; Nkhoma C; Katundu P; Mukiibi J; Chen S; Hoover D; Broadhead R
    Ann Trop Paediatr; 2004 Dec; 24(4):301-9. PubMed ID: 15720887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months.
    Shetty AK; Coovadia HM; Mirochnick MM; Maldonado Y; Mofenson LM; Eshleman SH; Fleming T; Emel L; George K; Katzenstein DA; Wells J; Maponga CC; Mwatha A; Jones SA; Abdool Karim SS; Bassett MT;
    J Acquir Immune Defic Syndr; 2003 Dec; 34(5):482-90. PubMed ID: 14657758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological Indices at Birth of Infants of HIV-Positive Mothers Participating in a Prevention of Mother-to-Child Transmission Program.
    Obumneme-Anyim I; Ibeziako N; Emodi I; Ikefuna A; Oguonu T
    J Trop Pediatr; 2016 Feb; 62(1):3-9. PubMed ID: 26411560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.